Alyeska Investment Group’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-61,820
Closed -$2.6M 512
2023
Q4
$2.6M Buy
+61,820
New +$2.6M 0.02% 338
2021
Q2
Sell
-377,309
Closed -$6.05M 769
2021
Q1
$6.05M Buy
+377,309
New +$6.05M 0.08% 286